Application Notes & Case Studies

图片名称
图片名称

Revolutionizing Cell Therapy Production: The 3D FloTrix™ vivaVIAL Filling System

Date : 2025-11-12


In our previous article A Brief Discussion on Packaging Material Selection for Commercial-Scale Cell-Based Therapy Production, we explored in depth the significant advantages of COP vials as final containers for cell formulations in terms of safety, stability, and cryo-tolerance. However, even the highest-quality packaging materials must be paired with precise and efficient filling equipment and processes to truly unlock their value.

For a long time, the filling process for stem cell formulations has heavily relied on manual or semi-automated operations. In the case of COP vials, the filling process remains largely at the semi-automated stage, involving manual filling, rubber stopper placement, and semi-automated crimping. This has not only created a major bottleneck for large-scale production but has also harbored multiple quality risks.

Drawbacks of Manual Cell Formulation Filling

     Difficulty in Quality Control

  1. Limited throughput for a single operator; Limited batch consistency across multiple operators.
  2. Unstable temperature control and inaccurate timing increase the risk of cell damage.
  3. Non-standardized manual mixing compromises the viability and uniformity of the cell suspension .

     High Cost

  1. Complex procedures require extensive manual operation and production documentation.

     High Contamination Risk

  1. Repeated and prolonged exposure of cell suspension and formulation during operation poses a high risk of microbial contamination.
  2. Aluminum debris generated during crimping may contaminate the product. Avoiding this requires segregated filling and crimping stations, increasing space requirements, labor, and exposure risks during transfer.
  3. Addressing these industry challenges, CytoNiche proudly introduces a groundbreaking solution—the 3D FloTrix™ vivaVIAL Filling System. More than a piece of equipment, it is a comprehensive solution designed specifically for the commercial-scale filling of cell-based therapeutics.

(Image: 3D FloTrix™ vivaMIX intelligent cell mixingmodule and 3D FloTrix™ vivaVIAL filling system

The 3D FloTrix™ vivaVIAL Filling System and 3D FloTrix™ vivaMIX Intelligent Cell Mixing Module are automated formulation filling platform specifically designed for the production of cell therapy products. Equipped with sterile single-use tubing kits, the system enables automated low-temperature mixing, material handling, filling, rubber stopper/aluminum cap placement, and crimping. It can achieve a throughput of thousands of vials per hour for cell formulations and cell-derived exosome formulations.

 

Technical Application Parameters

 

Application Areas

The 3D FloTrix™ vivaVIAL Filling System accommodates the filling process for a variety of cell formulations, exosome/lyophilized products, significantly enhancing both production efficiency and end-product quality.

 

Product Features

 

High-Precision Filling System


Intelligent Temperature-Controlled Mixing System


Intelligent Crimping System


Efficient and user-friendly

 

Application Data

The 3D FloTrix™ vivaVIAL Filling System is designed to overcome the key challenges in the transition from R&D to commercialisation. It not only improves filling efficiency but also establishes higher quality standards and a compliance-ready framework for cell-based drug manufacturing through automated, high-precision processes, accelerating the path to market.